Stock & Company Details
Aligos Therapeutics Inc $ALGS
Price:
46,691,331
5.4M
$35M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-0.42
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
ALGS technical indicators
Latest Aligos Therapeutics Inc (ALGS) indicator readings as of 2026-08-10.
ALGS's 14-day RSI is 75.5, in overbought territory. At $7.65 it is trading 5.5% above its 200-day moving average of $7.25, and above its 50-day average of $5.38. Price sits above the upper Bollinger Band ($3.37 to $6.83). ADX reads 24.4, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
Finance Bot
Ask your questions
Start by typing a question below.
